Showing 13 of 33 recruiting trials for “catastrophic-antiphospholipid-syndrome”
RecruitingNCT05786235 ↗
Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome
Enrolling by InvitationNCT05583305 ↗
Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
👨⚕️ Bonaventure Yiu Ming IP, MB ChB, Chinese University of Hong Kong📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT05230017 ↗
Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks
👨⚕️ Jiuliang Zhao, M.D., Peking Union Medical College Hospital📍 18 sites📅 Started Oct 2022View details ↗
RecruitingNCT05646394 ↗
Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
👨⚕️ Cary Clark, International Society on Thrombosis and Haemostasis📍 3 sites📅 Started Jul 2022View details ↗
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 2 sites📅 Started Jan 2022View details ↗
RecruitingNCT04308564 ↗
Laboratory and Clinical Data in Antiphospholipid Patients
RecruitingNCT04262492 ↗
International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
RecruitingNCT07178925 ↗
Follow-up Cohort of Patients With Antiphospholipid Syndrome
RecruitingNCT03890601 ↗
New Biological Tests in Patients With Antiphospholipid Antibodies
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
RecruitingNCT00616317 ↗
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
RecruitingNCT00482794 ↗
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
RecruitingNCT00198068 ↗
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
👨⚕️ Jane E. Salmon, M.D., Hospital for Special Surgery, New York📍 10 sites📅 Started Sep 2003View details ↗
← PreviousPage 2 of 2
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →